Dr. Jeffrey L. Halaas, MD
- Medicare services, 2024
- 82,849
- Medicare patients, 2024
- 674
- Part D claims, 2024
- 1,702
- Clinical trials
- 1
- Hospital affiliations
- 2
- Practice address
- 90 S Bedford Rd, Mount Kisco, NY 10549
- Practice phone
- Call (914) 241-1050
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Caremount Medical
Mount Kisco, New York
Find Dr. Halaas' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jeffrey L. Halaas is a hematologist and oncologist in Mount Kisco, New York
Dr. Halaas practices at Caremount Medical in Mount Kisco, New York.
Dr. Halaas' NPI, 1851346928, was assigned on May 24, 2006. Dr. Halaas holds New York license 219677.
- NPI
- 1851346928NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2668496092
- NPI enumeration date
- May 24, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (914) 241-1050
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jeffrey L. Halaas practices at Caremount Medical in Mount Kisco, New York
Dr. Halaas' primary practice is Caremount Medical, at 90 S Bedford Rd, Mount Kisco, NY 10549 in Westchester County. The practice phone is (914) 241-1050.
- Caremount Medical90 S Bedford Rd, Mount Kisco, NY 10549 · Westchester CountyPhone(914) 241-1050
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Jeffrey L. Halaas is affiliated with 4 sites of care and 1 medical group
Dr. Halaas' primary practice is Caremount Medical in Mount Kisco, New York. Dr. Halaas is also affiliated with Northern Westchester Hospital. The medical group on file is CareMount Medical. Dmand AI also links Dr. Halaas to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jeffrey L. Halaas' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halaas practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Caremount Medical | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jeffrey L. Halaas is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Halaas' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Halaas is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Halaas
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jeffrey L. Halaas billed Medicare for 82,849 services in 2024
CMS data shows 82,849 Medicare services from Dr. Halaas across 49 procedure codes in 2024, for 674 Medicare patients. Medicare paid $877,365 for them. Every service was in an office.
Dr. Halaas' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 63,2502024: 51,16819%
- Other services
- 2023: 49,2862024: 23,91951%
- Lab and pathology
- 2023: 4,1312024: 3,25821%
- Office and hospital visits
- 2023: 1,6092024: 1,6301%
- Surgery
- 2023: 1,6362024: 1,5744%
- Tests and treatments
- 2023: 2,0762024: 1,30037%
Dr. Halaas compared with the New York median for hematologists and oncologists, 2024
- Dr. Halaas
- New York median
- Medicare services
- 82,849vs 668124.0 times
- Medicare patients
- 674vs 2103.2 times
- Part D claims
- 1,385vs 2585.4 times
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Halaas' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Halaas?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Halaas and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jeffrey L. Halaas treated 674 Medicare patients in 2024, average age 76
CMS counts 674 Medicare patients who saw Dr. Halaas in 2024. The largest group is 75 to 84, with 288 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Halaas' median patient age at 69, with 58% women.
Dr. Halaas' Medicare patients by age, 2024
Dr. Halaas' Medicare patients by sex, 2024
- Women34751%
- Men32749%
Chronic conditions among Dr. Halaas' Medicare patients, 2024
- High cholesterol75%
- High blood pressure74%
- Arthritis45%
- Cancer39%
- Ischemic heart disease37%
- Chronic kidney disease36%
- Diabetes27%
- Anxiety24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Halaas' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women58%
- Men38%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jeffrey L. Halaas wrote 1,702 Medicare Part D claims in 2024
In 2024, Dr. Halaas wrote 1,702 Medicare Part D claims for 275 patients. 69% of them were for generic drugs. CMS names the drug for 1,385 of them, across 38 drugs with 11 or more claims each, at $4,685,311 in total drug cost. In 2023, CMS named 1,378 claims across 38 drugs.
Dr. Halaas' Part D claims by kind of drug, 2024
- Generic1,176 claims69%
- Brand-name526 claims31%
Dr. Halaas' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Halaas' Part D claims, 2024
- Opioids5%84 of 1,702 claims
- Antibiotics2%31 of 1,702 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,3782024: 1,3851%
Drugs named by CMS: 38 in 2024, 38 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jeffrey L. Halaas offers telehealth to Medicare patients
Dr. Halaas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Halaas as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jeffrey L. Halaas has worked on 1 clinical trial
Dmand AI links Dr. Halaas to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.
Conditions in Dr. Halaas' trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Halaas
Recent clinical trials with Dr. Halaas
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jeffrey L. Halaas received $47 in industry payments from 2019 to 2022
CMS Open Payments shows 4 general payments to Dr. Halaas from 4 drug and device companies from 2019 to 2022. Education make up the largest share, 74% of the total. Karyopharm Therapeutics Inc. paid the most, $12.
General payments to Dr. Halaas by program year, 2019 to 2022
General payments to Dr. Halaas by kind, 2019 to 2022
- Education$3474%
- Debt forgiveness$1226%
Companies that paid Dr. Halaas the most, 2019 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Jeffrey L. Halaas's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jeffrey L. Halaas
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jeffrey L. Halaas' NPI number?
Dr. Jeffrey L. Halaas' NPI number is 1851346928. It was assigned on May 24, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Jeffrey L. Halaas?
Dr. Jeffrey L. Halaas is a hematologist and oncologist in Mount Kisco, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jeffrey L. Halaas practice?
Dr. Halaas practices at 90 S Bedford Rd, Mount Kisco, NY 10549. Dr. Halaas' primary practice is Caremount Medical in Mount Kisco, New York. Dmand AI also links Dr. Halaas to 1 hospital and 1 group practice or clinic.
What is Dr. Jeffrey L. Halaas' office phone number?
The practice phone on file for Dr. Halaas is (914) 241-1050.
What is Dr. Jeffrey L. Halaas' medical license number?
Dr. Halaas holds New York license 219677.
Which hospitals is Dr. Jeffrey L. Halaas affiliated with?
Dr. Halaas is affiliated with Northern Westchester Hospital. Dmand AI links Dr. Halaas to 1 more hospital.
What medical group is Dr. Jeffrey L. Halaas part of?
Dr. Halaas is linked to CareMount Medical.
Does Dr. Jeffrey L. Halaas accept Medicare?
Yes. CMS data shows Dr. Halaas billed Medicare for 82,849 services in 2024, and Dr. Halaas accepts Medicare assignment.
Does Dr. Jeffrey L. Halaas offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Halaas as offering telehealth services.
How many Medicare patients does Dr. Jeffrey L. Halaas see?
CMS counts 674 Medicare patients who saw Dr. Halaas in 2024, with an average age of 76.
Show 5 more questionsShow fewer questions
What services does Dr. Jeffrey L. Halaas bill to Medicare?
In 2024, Dr. Halaas' most billed Medicare services were injected or infused drug (J0881), medicare temporary code (Q0138) and injected or infused drug (J9271).
What drugs does Dr. Jeffrey L. Halaas prescribe most?
In 2024 Medicare Part D data, Dr. Halaas' most prescribed drugs by claims were Hydroxyurea, Anastrozole and Prednisone.
Has Dr. Jeffrey L. Halaas received payments from drug or device companies?
CMS Open Payments shows $47 in general payments to Dr. Halaas from 4 companies from 2019 to 2022. The largest total came from Karyopharm Therapeutics Inc.
How long has Dr. Jeffrey L. Halaas been practicing?
Dr. Halaas graduated from medical school in 1996, 30 years ago.
Does Dr. Jeffrey L. Halaas do research?
Dr. Halaas has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card